Vimarsana
Biggest News Aggregation in the World

Page 17 - License Application News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from License Application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In License Application Today - Breaking & Trending Today

LTO's PITX Licensing Center generates P16.8M revenue since February 2022 - Vimarsana News

LTO's PITX Licensing Center generates P16.8M revenue since February 2022

The licensing center of the Land Transportation Office at the Parañaque Integrated Terminal Exchange (PITX) has generated P16.8 million in revenue after issuing more than 44,000 driver’s licenses and permits since it opened in February last year. Roque Verzosa III, director of the LTO-National Ca

Source: mb.com.ph
Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for Pegunigalsidase Alfa for Treatment of Fabry Disease - Vimarsana News

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for Pegunigalsidase Alfa for Treatment of Fabry Disease

/PRNewswire/ -- Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected...

YMAB LAWSUIT ALERT: Levi & Korsinsky Notifies Y-mAbs Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - Vimarsana News

YMAB LAWSUIT ALERT: Levi & Korsinsky Notifies Y-mAbs Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Y-mAbs Therapeutics, Inc. ("Y-mAbs" or the "Company") (NASDAQ: YMAB) of a class action securities...

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Y-mAbs Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 20, 2023 - Vimarsana News

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Y-mAbs Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 20, 2023

/PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Y-mAbs Therapeutics, Inc.. Shareholders who purchased shares of YMAB during...

YMAB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 20, 2023 in the Class Action Filed on Behalf of Y-mAbs Therapeutics, Inc. Shareholders - Vimarsana News

YMAB ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 20, 2023 in the Class Action Filed on Behalf of Y-mAbs Therapeutics, Inc. Shareholders

/PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB)...